Investing in a sustainability revolution
Listen now
Description
Keystone Positive Change’s Kate Fox on thinking about the world in 2050 to spot opportunities today.Background:Kate’s conversation with Malcolm Borthwick covers her work with the Deep Transitions Futures project, coordinated by the University of Sussex and Utrecht University and supported by Baillie Gifford.The project aims to identify patterns and insights from past ‘deep transitions’, such as the Industrial Revolution, to inform and guide our approach to identifying solutions to present and future challenges. These include climate change, social inequality, and biodiversity loss. The initiative seeks to develop strategies for fostering radical innovation. It engages investors, policymakers and researchers, among other stakeholders, to promote a transformative investment philosophy and drive systemic change.Resources:The second deep transition: Johan Schot’s theory of radical change (https://www.bailliegifford.com/?insights/ic-article/2022-q3-enlightenment-a-theory-of-radical-change-10015806)Deep Transitions Futures project (https://deeptransitions.net/future/about/)Previous Short Briefings on Long Term Thinking episodes (https://www.bailliegifford.com/en/uk/individual-investors/short-briefings-on-long-term-thinking)Follow us via:Twitter (https://twitter.com/bailliegifford)LinkedIn (https://www.linkedin.com/company/baillie-gifford/mycompany/)Companies mentioned include:Beyond Meat (https://www.beyondmeat.com/en-GB/)Deere (https://www.deere.com/en/)Northvolt (https://northvolt.com/)Tesla (https://www.tesla.com/)Umicore (https://www.umicore.com/en/)
More Episodes
Emerging markets have sometimes promised more than they have delivered, but circumstances may be tipping in growth investors’ favour. Will Sutcliffe, head of our Emerging Markets Team, explains why it’s an opportune time to invest in the asset class. Background: Will Sutcliffe is the head of...
Published 04/15/24
A new medicine that can help patients lose 15 per cent of their body weight could have far-reaching consequences for healthcare. Wegovy mimics a hormone the gut releases, reducing appetite and slowing digestion to delay hunger’s return. Research is also underway into other potential health...
Published 02/07/24